Alzheimer's disease as a neurodegenerative disorder and the apolipoprotein E gene as its genetic biomarker

Abstract

Alzheimer's disease (AD) is a progressive brain disorder that slowly destroys memory and thinking and functional skills. Alzheimer's disease is classified into two familial and sporadic types. Alzheimer's disease is also divided into the early or late onset of symptoms, with early-onset before age 65 and late-onset after this age. Symptoms of this disease appear in 4 stages: pre-dementia, early, middle and advanced. Many factors are involved in the pathophysiology of this disease. These include oxidative stress, inflammation, and genetics. Oxidative stress occurs with the involvement of beta-amyloid in mitochondrial function. Inflammation also results from the release of beta-amyloid in the brain and the release of inflammatory cytokines. The genes APP, presenilin 1, presenilin 2, and apolipoprotein (ApoE) play a key role in Alzheimer's disease. Due to the important role of the ApoE gene in this disease, common varieties and mutations of this gene can be considered as potential biomarkers of AD. This aimed to review the study was to describe the characteristics of Alzheimer's disease and also to introduce the ApoE gene as a biomarker of this disease.

Authors and Affiliations

Amirhossein Sahebkar; Farnaz Mohajertehran; Aida Gholoobi

Keywords

Related Articles

Central giant cell granuloma of maxillary bone in pediatric patient: A case report

Central Giant Cell Granuloma (CGCG) is a benign, intraosseous osteolytic lesion which often affects the mandible and its’ pathophysiology is not fully understood. Histopathology is still the dominant diagnostic method fo...

Anosmia induced by Covid-19: possible mechanisms of its induction and the strategy of stem cells therapy in restoring the sense of smell

By determining the quality of food, the sense of smell can play a protective role in humans and determine the suitability of a food for consumption. Sometimes anosmia is presented as a possible disease, and some only pre...

Stroke as a neurodegenerative disease; a review of the introduction, epidemiology, diagnosis, complications and causes

Ischemic stroke is a cardiovascular disease that accounts for many deaths and disabilities in developed and developing countries. Stroke can be an ischemic, hemorrhagic, or transient ischemic attack (TIA). Ischemic or ob...

Triple-negative breast cancer: biology, pathology, and treatment

Triple negative breast cancer (TNBC) is a subtype of breast tumor which comprises 24% of newly diagnosed tumors that lacks hormone receptor expression and HER2 gene amplification. This study illustrated the pathological...

Stem cell therapy as a promising approach in the treatment of neurodegenerative disorders

Neurodegenerative diseases in humans such as Parkinson's disease, Alzheimer's disease, stroke, multiple sclerosis, and Huntington's disease are associated with the loss of neurons or glial cells in the central nervous sy...

Download PDF file
  • EP ID EP714367
  • DOI 10.22034/CAJMPSI.2021.05.01
  • Views 55
  • Downloads 0

How To Cite

Amirhossein Sahebkar; Farnaz Mohajertehran; Aida Gholoobi (2021). Alzheimer's disease as a neurodegenerative disorder and the apolipoprotein E gene as its genetic biomarker. Central Asian Journal of Medical and Pharmaceutical Sciences Innovation, 1(5), -. https://europub.co.uk./articles/-A-714367